Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Synergy Pharmaceuticals Inc.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL alum Martin Goebel to exhibit work at the Smithsonian Craft Show
Goebel, who earned his BFA in studio art from UMSL in 2008, will be one of only a handful of furniture makers from across the country featured in the show.
MORE IN Synergy Pharmaceuticals Inc.
LATEST NEWS
- UMSL alum Martin Goebel to exhibit work at the Smithsonian Craft Show
- Elaina Rohlfing finds calling in computer science at UMSL, begins pursuit of PhD
- UMSL students chosen to perform with Missouri All-Collegiate Orchestra at Missouri Music Educators Association Conference
- Study Abroad Fair exposes UMSL students to world of possibilities as they look to expand their academic experience
- Eye on UMSL: Hitting the books
- Eye on UMSL: Snow day
- UMSL Tritons weekly rewind
- Chancellor Kristin Sobolik joins Pulse of St. Louis to discuss how UMSL is changing to meet the needs of students and St. Louis region
- UMSL alum and retiring St. Louis Mercantile Library curator Julie Dunn-Morton helps create new art gallery as legacy project
- US News ranks UMSL 11th nationally for Best Online Bachelor’s Programs
